Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Massaia

Showing results (81-90 of 89) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 89 results.
Haematologica|November 14, 2000
Antitumor vaccination: where we standM Bocchia, V Bronte, M P Colombo, et al.
Leukemia|March 5, 2011
IGHV unmutated CLL B cells are more prone to spontaneous apoptosis and subject to environmental prosurvival signals than mutated CLL B cellsM Coscia, F Pantaleoni, C Riganti, et al.
Leukemia|October 31, 2003
Multiple myeloma: comparison of two dose-intensive melphalan regimens (100 vs 200 mg/m(2))A Palumbo, S Bringhen, A Bertola, et al.
Leukemia|March 4, 2005
Effector gammadelta T cells and tumor cells as immune targets of zoledronic acid in multiple myelomaS Mariani, M Muraro, F Pantaleoni, et al.
Blood|July 9, 1999
Idiotype vaccination in human myeloma: generation of tumor-specific immune responses after high-dose chemotherapyM Massaia, P Borrione, S Battaglio, et al.
Leukemia|December 16, 2006
Acute myeloid leukemia cells constitutively express the immunoregulatory enzyme indoleamine 2,3-dioxygenaseA Curti, M Aluigi, S Pandolfi, et al.
Cytokine & Growth Factor Reviews|December 22, 2019
Anticancer innovative therapy: Highlights from the ninth annual meetingT Volpari, F De Santis, A P Bracken, et al.
Leukemia|April 3, 2009
Telomere length is an independent predictor of survival, treatment requirement and Richter's syndrome transformation in chronic lymphocytic leukemiaD Rossi, C Lobetti Bodoni, E Genuardi, et al.
American Journal of Hematology|January 24, 2024
Additional booster doses in patients with chronic lymphocytic leukemia induce humoral and cellular immune responses to SARS-CoV-2 similar to natural infection regardless ongoing treatments: A study by ERIC, the European Research Initiative on CLLA Campanella, A Capasso, S Heltai, et al.
Pageof 9

Showing results (81-90 of 89) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 89 results.
Haematologica|November 14, 2000
Antitumor vaccination: where we standM Bocchia, V Bronte, M P Colombo, et al.
Leukemia|March 5, 2011
IGHV unmutated CLL B cells are more prone to spontaneous apoptosis and subject to environmental prosurvival signals than mutated CLL B cellsM Coscia, F Pantaleoni, C Riganti, et al.
Leukemia|October 31, 2003
Multiple myeloma: comparison of two dose-intensive melphalan regimens (100 vs 200 mg/m(2))A Palumbo, S Bringhen, A Bertola, et al.
Leukemia|March 4, 2005
Effector gammadelta T cells and tumor cells as immune targets of zoledronic acid in multiple myelomaS Mariani, M Muraro, F Pantaleoni, et al.
Blood|July 9, 1999
Idiotype vaccination in human myeloma: generation of tumor-specific immune responses after high-dose chemotherapyM Massaia, P Borrione, S Battaglio, et al.
Leukemia|December 16, 2006
Acute myeloid leukemia cells constitutively express the immunoregulatory enzyme indoleamine 2,3-dioxygenaseA Curti, M Aluigi, S Pandolfi, et al.
Cytokine & Growth Factor Reviews|December 22, 2019
Anticancer innovative therapy: Highlights from the ninth annual meetingT Volpari, F De Santis, A P Bracken, et al.
Leukemia|April 3, 2009
Telomere length is an independent predictor of survival, treatment requirement and Richter's syndrome transformation in chronic lymphocytic leukemiaD Rossi, C Lobetti Bodoni, E Genuardi, et al.
American Journal of Hematology|January 24, 2024
Additional booster doses in patients with chronic lymphocytic leukemia induce humoral and cellular immune responses to SARS-CoV-2 similar to natural infection regardless ongoing treatments: A study by ERIC, the European Research Initiative on CLLA Campanella, A Capasso, S Heltai, et al.
Pageof 9